NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neomycin And Polymyxin B Sulfates And Gramicidin, and when can generic versions of Neomycin And Polymyxin B Sulfates And Gramicidin launch?
Neomycin And Polymyxin B Sulfates And Gramicidin is a drug marketed by Bausch And Lomb, Ipharm, Nordic Pharma, and Watson Labs. and is included in four NDAs.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN?
- What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN?
- What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 2 |
DailyMed Link: | NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN at DailyMed |